Terms: = Germ cell tumor AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Treatment
28 results:
1. Neuroblastoma: an ongoing cold front for cancer immunotherapy.
Kennedy PT; Zannoupa D; Son MH; Dahal LN; Woolley JF
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37993280
[TBL] [Abstract] [Full Text] [Related]
2. PhotoPyro-Induced cGAS-STING Pathway Activation Enhanced Anti-Melanoma Immunotherapy via a Manganese-Coordinated Nanomedicine.
Feng Y; Wang G; Li W; Yan J; Yu X; Tian H; Li B; Dai Y
Adv Healthc Mater; 2024 Mar; 13(6):e2302811. PubMed ID: 37909376
[TBL] [Abstract] [Full Text] [Related]
3. USP18 enhances the resistance of BRAF-mutated melanoma cells to vemurafenib by stabilizing cGAS expression to induce cell autophagy.
Ma ZR; Xiong QW; Cai SZ; Ding LT; Yin CH; Xia HL; Liu W; Dai S; Zhang Y; Zhu ZH; Huang ZJ; Wang Q; Yan XM
Int Immunopharmacol; 2023 Sep; 122():110617. PubMed ID: 37478666
[TBL] [Abstract] [Full Text] [Related]
4. Mitochondria Transfer from Mesenchymal Stem cells Confers Chemoresistance to Glioblastoma Stem cells through Metabolic Rewiring.
Nakhle J; Khattar K; Özkan T; Boughlita A; Abba Moussa D; Darlix A; Lorcy F; Rigau V; Bauchet L; Gerbal-Chaloin S; Daujat-Chavanieu M; Bellvert F; Turchi L; Virolle T; Hugnot JP; Buisine N; Galloni M; Dardalhon V; Rodriguez AM; Vignais ML
Cancer Res Commun; 2023 Jun; 3(6):1041-1056. PubMed ID: 37377608
[TBL] [Abstract] [Full Text] [Related]
5. A Therapeutic Vaccine in Combination with Cyclic gmp-AMP Cures More Differentiated Melanomas in Mice.
Alam MM; Gower T; Jiang M; Oppenheim JJ; Yang D
J Immunol; 2023 May; 210(9):1428-1436. PubMed ID: 36947147
[TBL] [Abstract] [Full Text] [Related]
6. Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer.
Huang H; Nie CP; Liu XF; Song B; Yue JH; Xu JX; He J; Li K; Feng YL; Wan T; Zheng M; Zhang YN; Ye WJ; Li JD; Li YF; Li JY; Cao XP; Liu ZM; Zhang XS; Liu Q; Zhang X; Liu JH; Li J
J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35727633
[TBL] [Abstract] [Full Text] [Related]
7. Rationally designed drug delivery systems for the local treatment of resected glioblastoma.
Bastiancich C; Malfanti A; Préat V; Rahman R
Adv Drug Deliv Rev; 2021 Oct; 177():113951. PubMed ID: 34461201
[TBL] [Abstract] [Full Text] [Related]
8. Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity.
McAndrews KM; Che SPY; LeBleu VS; Kalluri R
J Biol Chem; 2021; 296():100523. PubMed ID: 33711340
[TBL] [Abstract] [Full Text] [Related]
9. CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.
Huynh T; Murray J; Flemming CL; Kamili A; Hofmann U; Cheung L; Roundhill EA; Yu DMT; Webber HT; Schwab M; Henderson MJ; Haber M; Norris MD; Fletcher JI
Biochem Pharmacol; 2020 Feb; 172():113770. PubMed ID: 31862449
[TBL] [Abstract] [Full Text] [Related]
10. IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma.
Melief SM; Visser M; van der Burg SH; Verdegaal EME
Cancer Immunol Immunother; 2017 Jul; 66(7):913-926. PubMed ID: 28401257
[TBL] [Abstract] [Full Text] [Related]
11. Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T cells.
Tanaka M; Tashiro H; Omer B; Lapteva N; Ando J; Ngo M; Mehta B; Dotti G; Kinchington PR; Leen AM; Rossig C; Rooney CM
Clin Cancer Res; 2017 Jul; 23(14):3499-3509. PubMed ID: 28183713
[No Abstract] [Full Text] [Related]
12. Safe and Reproducible Preparation of Functional Dendritic cells for Immunotherapy in Glioblastoma Patients.
Nava S; Lisini D; Pogliani S; Dossena M; Bersano A; Pellegatta S; Parati E; Finocchiaro G; Frigerio S
Stem Cells Transl Med; 2015 Oct; 4(10):1164-72. PubMed ID: 26273063
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells.
Morita H; Murata T; Shimizu K; Okumura K; Inui M; Tagawa T
Oncol Rep; 2013 Apr; 29(4):1275-84. PubMed ID: 23381931
[TBL] [Abstract] [Full Text] [Related]
14. An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma.
Nava S; Dossena M; Pogliani S; Pellegatta S; Antozzi C; Baggi F; Gellera C; Pollo B; Parati EA; Finocchiaro G; Frigerio S
PLoS One; 2012; 7(12):e52301. PubMed ID: 23284979
[TBL] [Abstract] [Full Text] [Related]
15. Cyclic gmp-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines.
Swartling FJ; Ferletta M; Kastemar M; Weiss WA; Westermark B
Oncogene; 2009 Sep; 28(35):3121-31. PubMed ID: 19543319
[TBL] [Abstract] [Full Text] [Related]
16. gmp production of pDERMATT for vaccination against melanoma in a phase I clinical trial.
Quaak SG; van den Berg JH; Toebes M; Schumacher TN; Haanen JB; Beijnen JH; Nuijen B
Eur J Pharm Biopharm; 2008 Oct; 70(2):429-38. PubMed ID: 18606527
[TBL] [Abstract] [Full Text] [Related]
17. Four cardiac hormones cause cell death of melanoma cells and inhibit their DNA synthesis.
Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
Am J Med Sci; 2007 Nov; 334(5):342-9. PubMed ID: 18004088
[TBL] [Abstract] [Full Text] [Related]
18. 3',5'-Cyclic diguanylic acid (c-di-gmp) inhibits basal and growth factor-stimulated human colon cancer cell proliferation.
Karaolis DK; Cheng K; Lipsky M; Elnabawi A; Catalano J; Hyodo M; Hayakawa Y; Raufman JP
Biochem Biophys Res Commun; 2005 Apr; 329(1):40-5. PubMed ID: 15721270
[TBL] [Abstract] [Full Text] [Related]
19. Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy.
Heinzerling L; Burg G; Dummer R; Maier T; Oberholzer PA; Schultz J; Elzaouk L; Pavlovic J; Moelling K
Hum Gene Ther; 2005 Jan; 16(1):35-48. PubMed ID: 15703487
[TBL] [Abstract] [Full Text] [Related]
20. Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer.
Goffin JR; Straume O; Chappuis PO; Brunet JS; Bégin LR; Hamel N; Wong N; Akslen LA; Foulkes WD
Br J Cancer; 2003 Sep; 89(6):1031-4. PubMed ID: 12966421
[TBL] [Abstract] [Full Text] [Related]
[Next]
